These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tardive dyskinesia: a role for the endogenous opioid system. Sandyk R Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480 [TBL] [Abstract][Full Text] [Related]
4. Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors. See RE; Aravagiri M; Ellison GD Life Sci; 1989; 44(3):229-36. PubMed ID: 2536879 [TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia and current dose of neuroleptic drugs. Kolakowska T; Williams AO; Ardern M Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034 [No Abstract] [Full Text] [Related]
6. Induction of tardive dyskinesia in Cebus apella and Macaca speciosa monkeys: a review. Domino EF Psychopharmacology Suppl; 1985; 2():217-23. PubMed ID: 2860660 [TBL] [Abstract][Full Text] [Related]
8. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol. Schweitzer JW; Schwartz R; Friedhoff AJ Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618 [TBL] [Abstract][Full Text] [Related]
9. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies. Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476 [TBL] [Abstract][Full Text] [Related]
10. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? Jeste DV; Wyatt RJ J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358 [TBL] [Abstract][Full Text] [Related]
12. Oral tardive dyskinesia in the rat. Sundén-Kuronen B; Pohto P; Alanen E Acta Odontol Scand; 1983 Dec; 41(6):343-8. PubMed ID: 6581673 [TBL] [Abstract][Full Text] [Related]
13. Tardive dyskinesia: review and update. Klawans HL; Goetz CG; Perlik S Am J Psychiatry; 1980 Aug; 137(8):900-8. PubMed ID: 6106395 [TBL] [Abstract][Full Text] [Related]
14. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid. Bishnoi M; Chopra K; Kulkarni SK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775 [TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia and current dose of neuroleptic drugs. Kolakowska T; Williams AO; Ardern M Arch Gen Psychiatry; 1986 Jun; 43(6):614. PubMed ID: 2871820 [No Abstract] [Full Text] [Related]
16. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia. Yarbrough GG; Faison EP; Antolik EK Neurosci Lett; 1982 Dec; 34(3):321-3. PubMed ID: 6819493 [TBL] [Abstract][Full Text] [Related]